Eric Umbreit

Associate Prof and Fellowship Director at UT Health San Antonio | Urologic Oncology | Dreaming of Powder

[Eric Umbreit @umbreite]

@urorogerio @RoboticsUrology @SimplyUroMD @asajimd Ureteral reconstruction is an absolute home run with the single-port approach, anywhere renal pelvis to the bladder.

[Eric Umbreit @umbreite]

@CanesDavid Mine is slowly growing...

[Eric Umbreit @umbreite]

Wow. Tremendous resource. Thank you @lee_c_zhao for the share.

[Lee Zhao @lee_c_zhao]

I’ve created a dedicated Surgical Video Library at https://t.co/i1ZpZkmjXj

Patients and colleagues frequently ask for specific videos from my procedures. Rather than searching through YouTube, this AI-powered site allows easy keyword search across my entire collection. I can also edit and update content directly.

Feedback welcome. @AmerUrological @SocietyGURS @SocietySURS

[Eric Umbreit @umbreite]

The single-port robotic platform keeps providing novel solutions. We used it for nephropexy — unlocking fast recovery with LARA, hiding the incision in a younger patient, and getting an excellent outcome.

https://t.co/0EkeRKKynu

#Urology #SP #RoboticSurgery

[Eric Umbreit @umbreite]

@DrMBWesterman @LauraBukavinaMD This is my experience too. WGS seems better, but we will have more data over the next couple years.

[Eric Umbreit @umbreite]

Great guide if you are new to Claude Code and building an AI personal assistant. You definitely hit limits when getting it up and running.

How to stop hitting Claude usage limits. https://t.co/0aUsl69pfA

[Eric Umbreit @umbreite]

@beschur @WellPrept Completely agree. Also got me on the Obsidian + Claude combo

[Ben Schurhamer, MD @beschur]

Following David's advice has transformed my clinical practice - from @WellPrept, Ambient Scribes (they use #heidi, charting and epic efficiency - it has been a masterclass in augmenting the patient relationship with tech! #aua26

[Eric Umbreit @umbreite]

@JAMA_current These metrics don’t really capture the beauty of AI scribe. It saves me 1-2 hours every clinic; I listen, connect with and face my patients; I’m not exhausted at the end of clinic. I don’t prechart. It summarizes referrals. My notes are so much better and informative.@tryheidi

[Eric Umbreit @umbreite]

These metrics don’t really capture the beauty of AI scribe. It saves me 1-2 hours every clinic; I listen, connect with and face my patients; I’m not exhausted at the end of clinic. I don’t prechart. It summarizes referrals. My notes are so much better and informative.@tryheidi

[JAMA @JAMA_current]

#AI scribe adoption across 5 academic centers was associated with modest reductions in EHR and documentation time, plus a slight increase in weekly visit volume, especially for primary care and female clinicians.

https://t.co/KRiPl7J7yK

[Eric Umbreit @umbreite]

@GTumors @SUO_YUO @RichMatulewicz @SpiessPhilippe @drgaganprakash Yes. Hate to give chemo if futile.

[Eric Umbreit @umbreite]

@GTumors @SUO_YUO @RichMatulewicz @SpiessPhilippe @drgaganprakash Primary tumor histology has become a bigger part of patient counseling for me, especially Seminoma-Yolk Sac combination and increased risk of malignant transformation. https://t.co/0VHKYvS8lZ

This paper is another example of these concerns.

[Eric Umbreit @umbreite]

Primary tumor histology has become a bigger part of patient counseling for me, especially Seminoma-Yolk Sac combination and increased risk of malignant transformation. https://t.co/0VHKYvS8lZ

This paper is another example of these concerns.

[Global Society of Rare Genitourinary Tumors @GTumors]

Outcomes from 1027 pc-RPLNDs in NSGCT:

• Residual mass size correlates with higher rates of teratoma and yolk sac tumor

• Primary tumor histology associated with RPLND pathology

🔗 https://t.co/pyVq7RF1x9

@RichMatulewicz @SpiessPhilippe @SpiessPhilippe @drgaganprakash @LuisMedinaMD @npaesa @CMercinelli @dramandeeparora @CurtisPettaway1 @MDAndersonNews @MoffittNews @TataMemorial @MUSC_UroOnc @AmerUrological @UroOnc @SUO_YUO @CAU_URO @AndreaNecchi @orchidcancer @ERN_eUROGEN @EauPatient @JadChahoud

[Bishal Gyawali, MD, PhD, FASCO @oncology_bg]

A MUST-READ!

This is probably one of my most important papers where I try to teach how to fish rather than offer fish.

How I Read a Clinical Trial Report?

BG’s primer for Busy Clinicians.

Thank you @JCOOP_ASCO @EthicsdoctorP for the kind invitation. I hope the readers will find this useful.

https://t.co/HJhZlsBpU2

[Eric Umbreit @umbreite]

@RoboticsUrology Are you retroperiteal there? Via the LARA on the right?

[JAMA @JAMA_current]

"Medicine can have extraordinary meaning. But it cannot substitute for being present in your own life."

In #APieceofMyMind, a psychiatrist and residency program director reflects on an unexpected #LungCancer diagnosis.

https://t.co/V3Tae6P6mU

[Eric Umbreit @umbreite]

@daviesbj Agree entirely. But, we are very protected from frontline issues as academic urologists. Residents and extenders shield us. I would feel very different if I was receiving the 3 am catheter consult or intractable hematuria with clot retention.

[Bogdana Schmidt MD, MPH @BogdanaSchmidt]

Excited to speak at #AUA26! Join me and Neal D. Shore, MD, FACS for a @PeerView Live symposium on personalized, risk-adapted approaches to #NMIBC. May 16 at 6:00 PM EDT in Washington, DC or virtually: https://t.co/HpkXAkrvdO
#Urology #MedEd

[Eric Umbreit @umbreite]

@pash22 @tryheidi @MaxTopaz @CanesDavid I have had zero of these issues that I remember. If you AI scribe is doing this, switch to @tryheidi

[Andrew Vickers @VickersBiostats]

Just saw geology undergraduate final presentations @CarletonCollege. Way better presentational, statistical and causal reasoning skills than at typical medical conferences. Why we aren’t teaching our fellows and residents better, given that, you know, lives are at stake?